Grifols SA (GRFS)
7.985
-0.02
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.985
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.2631 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2631 |
| March 31, 2026 | 0.1255 |
| December 31, 2025 | 0.168 |
| September 30, 2025 | 0.2183 |
| June 30, 2025 | 0.1952 |
| March 31, 2025 | 0.0924 |
| December 31, 2024 | 0.1081 |
| September 30, 2024 | 0.0836 |
| June 30, 2024 | 0.0235 |
| March 31, 2024 | 0.0342 |
| December 31, 2023 | 0.0895 |
| September 30, 2023 | 0.0896 |
| June 30, 2023 | 0.0612 |
| March 31, 2023 | -0.0168 |
| March 31, 2021 | 0.2286 |
| December 31, 2020 | 0.2314 |
| September 30, 2020 | 0.4566 |
| June 30, 2020 | 0.0513 |
| March 31, 2020 | 0.3001 |
| December 31, 2019 | 0.3265 |
| September 30, 2019 | 0.2219 |
| June 30, 2019 | 0.2833 |
| March 31, 2019 | 0.1899 |
| December 31, 2018 | 0.2142 |
| September 30, 2018 | 0.254 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3058 |
| March 31, 2018 | 0.2578 |
| December 31, 2017 | 0.4003 |
| September 30, 2017 | 0.2702 |
| June 30, 2017 | 0.2313 |
| March 31, 2017 | 0.2091 |
| December 31, 2016 | 0.2155 |
| September 30, 2016 | 0.2344 |
| June 30, 2016 | 0.2258 |
| March 31, 2016 | 0.1985 |
| December 31, 2015 | 0.208 |
| September 30, 2015 | 0.2279 |
| June 30, 2015 | 0.2157 |
| March 31, 2015 | 0.2136 |
| December 31, 2014 | 0.2373 |
| September 30, 2014 | 0.2186 |
| June 30, 2014 | 0.2057 |
| March 31, 2014 | 0.2411 |
| December 31, 2013 | 0.1565 |
| September 30, 2013 | 0.1655 |
| June 30, 2013 | 0.1763 |
| March 31, 2013 | 0.1782 |
| December 31, 2012 | 0.1167 |
| September 30, 2012 | 0.1191 |
| June 30, 2012 | 0.1221 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.1472 |
| argenx SE | -- |
| Evaxion AS | -0.4464 |
| Akari Therapeutics Plc | -2.404 |
| Pharma Mar SA | -0.0652 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 212.78M |
| Revenue (Quarterly) | 2.179B |
| Total Expenses (Quarterly) | 2.000B |
| Enterprise Value | 14.00B |
| Gross Profit Margin (Quarterly) | 37.57% |
| Profit Margin (Quarterly) | 9.77% |
| Earnings Yield | 9.70% |
| Operating Earnings Yield | 25.86% |
| Normalized Earnings Yield | 9.704 |